Browsing by Subject
Now showing items 1-1 of 1
-
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
(American Association for Cancer Research, 2024-02-15)